Tejaswini Subbannayya

Tejaswini Subbannayya

Auto-generated profile, based on publicly available information

Tejaswini Subbannayya

Institute of Bioinformatics International Technology Park Bangalore India

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 May 2014 in Nature
Verified
Journal Article
Open access
PDF file
Min-Sik KimMin-Sik Kim
Min-Sik Kim
SPSneha Maria Pinto
Sneha Maria Pinto
DGDerese Getnet
Derese Getnet
RNRaja Sekhar Nirujogi
Raja Sekhar Nirujogi
SMSrikanth S. Manda
Srikanth S. Manda
APAkhilesh Pandey
Akhilesh Pandey
The availability of human genome sequence has transformed biomedical research over the past decade. However, an equivalent map for the human proteome with direct measurements of proteins and peptides does not exist yet. Here we present a draft map of the human proteome using high-resolution Fourier-transform mass spectrometry. In-depth proteomic profiling of 30 histologically normal human samples, including 17 adult tissues, 7 fetal tissues and 6 purified primary haematopoietic cells, resulted in identification of proteins encoded by 17,294 genes accounting for approximately 84% of the total annotated protein-coding genes in humans. A unique and comprehensive strategy for proteogenomic analysis enabled us to discover a number of novel protein-coding regions, which includes translated pseudogenes, non-coding RNAs and upstream open reading frames. This large human proteome catalogue (available as an interactive web-based resource at http://www.humanproteomemap.org) will complement available human genome and transcriptome data to accelerate biomedical research in health and disease.

9 June 2012 in Journal of Cell Communication and Signaling
Verified
Journal Article
Closed access
PDF file
ARAneesha Radhakrishnan
Aneesha Radhakrishnan
RRRajesh Raju
Rajesh Raju
NTNirvana Tuladhar
Nirvana Tuladhar
TSTejaswini Subbannayya
Tejaswini Subbannayya
JTJoji Kurian Thomas
Joji Kurian Thomas
ACAditi Chatterjee
Aditi Chatterjee

24 August 2020 in Nature Communications
Verified
Journal Article
Open access
PDF file
APAkhilesh Pandey
Akhilesh Pandey
ESEric W. Stawiski
Eric W. Stawiski
SDSteffen Durinck
Steffen Durinck
HGHarsha Gowda
Harsha Gowda
LGLeonard D. Goldstein
Leonard D. Goldstein
SSSomasekar Seshagiri
Somasekar Seshagiri
Gallbladder cancer (GBC) is an aggressive gastrointestinal malignancy with no approved targeted therapy. Here, we analyze exomes (n = 160), transcriptomes (n = 115), and low pass whole genomes (n = 146) from 167 gallbladder cancers (GBCs) from patients in Korea, India and Chile. In addition, we also sequence samples from 39 GBC high-risk patients and detect evidence of early cancer-related genomic lesions. Among the several significantly mutated genes not previously linked to GBC are ETS domain genes ELF3 and EHF, CTNNB1, APC, NSD1, KAT8, STK11 and NFE2L2. A majority of ELF3 alterations are frame-shift mutations that result in several cancer-specific neoantigens that activate T-cells indicating that they are cancer vaccine candidates. In addition, we identify recurrent alterations in KEAP1/NFE2L2 and WNT pathway in GBC. Taken together, these define multiple targetable therapeutic interventions opportunities for GBC treatment and management.

1 November 2014 in Molecular & Cellular Proteomics
Verified
Journal Article
Open access
PDF file
DKDhanashree S. Kelkar
Dhanashree S. Kelkar
EPElayne Provost
Elayne Provost
RCRaghothama Chaerkady
Raghothama Chaerkady
BMBabylakshmi Muthusamy
Babylakshmi Muthusamy
SMSrikanth S. Manda
Srikanth S. Manda
APAkhilesh Pandey
Akhilesh Pandey
Accurate annotation of protein-coding genes is one of the primary tasks upon the completion of whole genome sequencing of any organism. In this study, we used an integrated transcriptomic and proteomic strategy to validate and improve the existing zebrafish genome annotation. We undertook high-resolution mass-spectrometry-based proteomic profiling of 10 adult organs, whole adult fish body, and two developmental stages of zebrafish (SAT line), in addition to transcriptomic profiling of six organs. More than 7,000 proteins were identified from proteomic analyses, and ∼69,000 high-confidence transcripts were assembled from the RNA sequencing data. Approximately 15% of the transcripts mapped to intergenic regions, the majority of which are likely long non-coding RNAs. These high-quality transcriptomic and proteomic data were used to manually reannotate the zebrafish genome. We report the identification of 157 novel protein-coding genes. In addition, our data led to modification of existing gene structures including novel exons, changes in exon coordinates, changes in frame of translation, translation in annotated UTRs, and joining of genes. Finally, we discovered four instances of genome assembly errors that were supported by both proteomic and transcriptomic data. Our study shows how an integrative analysis of the transcriptome and the proteome can extend our understanding of even well-annotated genomes.

24 April 2020 in Gastric Cancer
Verified
Journal Article
Open access
PDF file
NBNiraj Babu
Niraj Babu
SPSneha Maria Pinto
Sneha Maria Pinto
MBManjusha Biswas
Manjusha Biswas
TSTejaswini Subbannayya
Tejaswini Subbannayya
MRManoj Rajappa
Manoj Rajappa
ACAditi Chatterjee
Aditi Chatterjee
Background Phosphorylation is an important regulatory mechanism of protein activity in cells. Studies in various cancers have reported perturbations in kinases resulting in aberrant phosphorylation of oncoproteins and tumor suppressor proteins. Methods In this study, we carried out quantitative phosphoproteomic analysis of gastric cancer tissues and corresponding xenograft samples. Using these data, we employed bioinformatics analysis to identify aberrant signaling pathways. We further performed molecular inhibition and silencing of the upstream regulatory kinase in gastric cancer cell lines and validated its effect on cellular phenotype. Through an ex vivo technology utilizing patient tumor and blood sample, we sought to understand the therapeutic potential of the kinase by recreating the tumor microenvironment. Results Using mass spectrometry-based high-throughput analysis, we identified 1,344 phosphosites and 848 phosphoproteins, including differential phosphorylation of 177 proteins (fold change cut-off ≥ 1.5). Our data showed that a subset of differentially phosphorylated proteins belonged to splicing machinery. Pathway analysis highlighted Cdc2-like kinase (CLK1) as upstream kinase. Inhibition of CLK1 using TG003 and CLK1 siRNA resulted in a decreased cell viability, proliferation, invasion and migration as well as modulation in the phosphorylation of SRSF2. Ex vivo experiments which utilizes patient’s own tumor and blood to recreate the tumor microenvironment validated the use of CLK1 as a potential target for gastric cancer treatment. Conclusions Our data indicates that CLK1 plays a crucial role in the regulation of splicing process in gastric cancer and that CLK1 can act as a novel therapeutic target in gastric cancer.

1 January 2011 in Database: The Journal of Biological Databases and Curation
Verified
Journal Article
Open access
PDF file
RRRajesh Raju
Rajesh Raju
VNVishalakshi Nanjappa
Vishalakshi Nanjappa
LBLavanya Balakrishnan
Lavanya Balakrishnan
ARAneesha Radhakrishnan
Aneesha Radhakrishnan
JTJoji Kurian Thomas
Joji Kurian Thomas
APAkhilesh Pandey
Akhilesh Pandey
We previously developed NetPath as a resource for comprehensive manually curated signal transduction pathways. The pathways in NetPath contain a large number of molecules and reactions which can sometimes be difficult to visualize or interpret given their complexity. To overcome this potential limitation, we have developed a set of more stringent curation and inclusion criteria for pathway reactions to generate high-confidence signaling maps. NetSlim is a new resource that contains this ‘core’ subset of reactions for each pathway for easy visualization and manipulation. The pathways in NetSlim are freely available at http://www.netpath.org/netslim. Database URL:www.netpath.org/netslim